Dariohealth CORP Form 4 insider transactions

Dennis Matheis, a Director of DarioHealth Corp., purchased 14,430 shares of common stock on August 12, 2024 for $6.93 per share.

DarioHealth Corp.'s President and CCO, Steven Charles Nelson, acquired 30,000 shares of common stock as a restricted award, increasing his beneficial ownership to 34,750 shares.

DarioHealth Corp. Director Adam K. Stern received an award of 20,000 restricted common shares, vesting in two years.

DarioHealth Corp. Director Lawrence B. Leisure was granted 20,000 restricted shares of common stock, vesting two years from the grant date, following a recent 20-for-1 reverse stock split.

DarioHealth Corp. Director Yoav Shaked reported the acquisition of 20,000 shares of common stock on September 11, 2025, as a restricted share award.

DarioHealth Corp.'s CEO, Erez Raphael, received a restricted share award of 60,000 common shares following a 20-for-1 reverse stock split.

DarioHealth Corp.'s Chief Financial Officer, Chen Franco-Yehuda, was granted 5,000 shares of common stock, vesting over two years, following a recent 20-for-1 reverse stock split.

DarioHealth Corp. Director Dennis M. McGrath was granted 20,000 shares of common stock on September 11, 2025, following a recent 20-for-1 reverse stock split.

DarioHealth Corp. Director Hila Karah acquired 20,000 shares of common stock as a restricted award, bringing her total beneficial ownership to 30,965 shares, following a recent 20-for-1 reverse stock split.

DarioHealth Corp. Director Dennis Matheis received a restricted share award of 20,000 common shares, bringing his total beneficial ownership to 27,631 shares, following a recent 20-for-1 reverse stock split.

DarioHealth Corp.'s President and CCO, Steven Charles Nelson, purchased 40,000 shares of common stock at $0.53 per share.

Chen Franco-Yehuda, CFO of DarioHealth Corp., acquired 500,000 shares of common stock on May 15, 2025, as reported in a Form 4 filing with the SEC.

Jon H. Kaplan, a director of DarioHealth Corp., acquired 30,000 shares of common stock on February 24, 2025.

Director Adam Stern reports changes in beneficial ownership of DarioHealth Corp. securities, including common stock and preferred stock, following a transaction on January 7, 2025.

DarioHealth Corp.'s Chief Commercial Officer, Steven Charles Nelson, purchased 5,000 shares of common stock at a price of $0.9092 per share.

Chief Commercial Officer Steven Nelson recently purchased 10,000 shares of DarioHealth Corp., signaling confidence in the company's future.

Chief Commercial Officer Steven Nelson recently purchased 15,000 shares of DarioHealth Corp., signaling confidence in the company's future.

DarioHealth Corp.'s CEO, Raphael Erez, purchased 5,000 shares of common stock at $0.88 per share on August 27, 2024.

Chief Commercial Officer Steven Nelson reports purchasing 15,000 shares of DarioHealth Corp. stock between August 21st and August 23rd, 2024.

DarioHealth Corp. CEO Raphael Erez recently purchased 10,000 shares of common stock, signaling confidence in the company.

Steven Nelson, Chief Commercial Officer of DarioHealth Corp., recently purchased 10,000 shares of the company's common stock in two separate transactions.

DarioHealth Corp. CEO Raphael Erez recently purchased additional shares of the company's common stock, signaling confidence in its future.

Steven Charles Nelson, Chief Commercial Officer of DarioHealth Corp., received stock options to purchase shares of common stock, according to a recent SEC filing.

DarioHealth Corp. CFO Zvi Ben-David reports acquiring 400,000 shares of common stock and disclaims beneficial ownership of 1,786 shares held by spouse.

Director Yoav Shaked reports acquiring 90,000 shares of DarioHealth Corp. common stock on March 6, 2024.

Richard Anderson, President of DarioHealth Corp., reports the acquisition of stock options in the company.

Jon Kaplan, a director of DarioHealth Corp., acquired 70,000 shares of common stock on March 6, 2024.

Director Hila Karah reports acquiring 70,000 shares of DarioHealth Corp. on March 6, 2024.

DarioHealth Corp. CEO Raphael Erez reports the acquisition of 800,000 shares of common stock and indirect beneficial ownership of 37,876 shares held by Dicilyon Consulting and Investment Ltd.

Director Dennis McGrath acquired 80,000 shares of DarioHealth Corp. common stock on March 6, 2024.